A new catheter designed to improve complex heart procedures
Catheter for Complex Percutaneous Coronary Intervention
This study is testing a new type of catheter designed to help doctors place stents more easily and safely in patients with severe heart artery blockages, especially when the arteries are tricky to navigate.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Crossliner INC NIH-funded |
| Lab location | 1 site (Kalamazoo, United States) |
| Project ID | NIH-11011323 on NIH RePORTER |
What this research studies
This research focuses on developing a novel guide extension catheter (GEC) to enhance the delivery of stents during complex percutaneous coronary interventions (PCIs). The new catheter aims to safely navigate challenging coronary anatomies, such as calcified lesions and tortuous vessels, which are often difficult to treat with existing devices. By incorporating a microcatheter leading tip and a pre-dilatation balloon, this approach seeks to improve the success rate of stent delivery in patients with severe coronary artery disease. The study will evaluate the effectiveness and safety of this innovative catheter in real-world clinical settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with complex coronary artery disease requiring percutaneous coronary interventions.
Not a fit: Patients with simple coronary artery disease or those who do not require stent placement may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve treatment outcomes for patients undergoing complex heart procedures.
How similar studies have performed: Previous research has shown promise in using guide extension catheters for complex cases, but this specific approach is novel and untested.
Where this research is happening
Kalamazoo, United States
- Crossliner INC — Kalamazoo, United States (Active)
Researchers
- Principal investigator: Fischell, Tim Alexander — Crossliner INC
- Study coordinator: Fischell, Tim Alexander
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.